Larson Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$933K Buy
4,434
+1,170
+36% +$235K 0.02% 390
2026
Q2
$621K Buy
3,264
+132
+4% +$22.7K 0.02% 496
2026
Q1
$529K Buy
3,132
+415
+15% +$71K 0.02% 463
2025
Q4
$458K Buy
2,717
+60
+2% +$9.7K 0.02% 483
2025
Q3
$384K Buy
2,657
+257
+11% +$35.1K 0.01% 534
2025
Q2
$304K Buy
2,400
+494
+26% +$60.6K 0.01% 565
2025
Q1
$244K Buy
1,906
+153
+9% +$20.7K 0.01% 583
2024
Q4
$232K Buy
1,753
+102
+6% +$14.3K 0.01% 535
2024
Q3
$240K Buy
1,651
+60
+4% +$8.68K 0.01% 525
2024
Q2
$218K Buy
1,591
+6
+0.4% +$801 0.01% 441
2024
Q1
$217K Buy
1,585
+153
+11% +$20.9K 0.02% 388
2023
Q4
$194K Buy
1,432
+57
+4% +$6.96K 0.02% 365
2023
Q3
$168K Buy
1,375
+200
+17% +$25.4K 0.02% 361
2023
Q2
$149K Buy
1,175
+96
+9% +$12.5K 0.01% 366
2023
Q1
$139K Buy
1,079
+5
+0.5% +$655 0.02% 374
2022
Q4
$141K Sell
1,074
-41
-4% -$5.3K 0.02% 354
2022
Q3
$130K Buy
1,115
+1,000
+870% +$124K 0.02% 326
2022
Q2
$14K Hold
115
– – ﹤0.01% 626
2022
Q1
$15K Sell
115
-38
-25% -$4.95K ﹤0.01% 570
2021
Q4
$23K Hold
153
– – ﹤0.01% 515
2021
Q3
$25K Hold
153
– – 0.01% 422
2021
Q2
$25K Buy
153
+38
+33% +$5.85K 0.01% 392
2021
Q1
$17K Hold
115
– – 0.01% 441
2020
Q4
$17K Buy
115
+70
+156% +$10K 0.01% 401
2020
Q3
$6K Hold
45
– – ﹤0.01% 503
2020
Q2
$6K Hold
45
– – ﹤0.01% 450
2020
Q1
$5K Hold
45
– – ﹤0.01% 365
2019
Q4
$5K Hold
45
– – ﹤0.01% 366
2019
Q3
$4K Hold
45
– – ﹤0.01% 382
2019
Q2
$5K Hold
45
– – ﹤0.01% 311
2019
Q1
$5K Hold
45
– – ﹤0.01% 292
2018
Q4
$4K Buy
+45
New +$4.78K ﹤0.01% 295

Other funds holding IBB

Larson Financial Group's IBB Position: Q3 2026 in Review

Larson Financial Group increased its iShares Biotechnology ETF (IBB) stake by 36% in Q3 2026, buying an estimated $235K and bringing the position to 4,434 shares worth $933K. The position accounts for 0.02% of the portfolio, ranked #390.

Larson Financial Group first reported a position in IBB in Q4 2018 and has held it in 32 quarters since. 1,027 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Larson Financial Group held 4,434 shares of iShares Biotechnology ETF worth $933K as of Q3 2026.
  • Larson Financial Group bought 1,170 iShares Biotechnology ETF shares in Q3 2026, an estimated $235K.
  • iShares Biotechnology ETF made up 0.02% of Larson Financial Group's portfolio in Q3 2026, its #390 holding.
  • Larson Financial Group first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 32 quarters since.
  • 1,027 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.